Podchaser Logo
Home
Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama

Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama

Released Monday, 10th January 2022
Good episode? Give it some love!
Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama

Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama

Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama

Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama

Monday, 10th January 2022
Good episode? Give it some love!
Rate Episode

Pfizer CEO Albert Bourla says the company will have an omicron vaccine ready by March, just in case. He discusses global vaccine distribution, the covid treatment pill, and what he’s hoping for in 2022 with CNBC’s Meg Tirrell, Becky Quick, and Andrew Ross Sorkin. SEC Chairman Gary Gensler discusses regulatory goals on his 2022 docket, including bolstering transparency for investors. Plus, China is attempting to mitigate a surge of Omicron before the Winter Olympics, and tennis champion Novak Djokovic’s Aussie drama continues, courtside. 

 

In this episode:

Gary Gensler, @GaryGensler

Albert Bourla, @AlbertBourla

Meg Tirrell, @megtirrell

Becky Quick, @BeckyQuick

Andrew Ross Sorkin, @andrewrsorkin

Cameron Costa, @CameronCostaNY

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features